mRNA COVID Vaccine Administration Policy

The data provided by the FDA indicates that the mRNA vaccines for COVID-19 manufactured by BioNTech cause cardiac events in 1:7000 patients. The fatality rate from COVID-19 is much less than that for healthy individuals. Therefore, these vaccines should not be to patients unless they are significantly immune compromised.

The process by which the vaccines were approved has demonstrated there are serious concerns about the ability of national central government to act in the best interests of its citizens. Consequently, local government bodies need to be strengthened and the central government needs to be weakened.

Immediate Actions:

• The use of these vaccines should be banned in all patients except for those with significant immunocompromise.

• The state should provide funding (~$450,000) for the following:

o Secure participation from each of the state’s 5 biotech research institutions (UNLV, UNR, DRI, Roseman, Touro).

o Two should write a protocol to that if executed correctly would verify or refute the claim that there is excessive potentially harmful DNA in the vaccines.

o Three others should execute the protocol.

o The first two should verify the protocol was executed correctly and present the results.

o Benefits:

▪ People in the state will see Nevada healthcare institutions working together to find answers to questions that concern all of us, thereby improving their perceptions of healthcare in Nevada and our research institutions.

▪ It will set the precedent for the research institutions to work together on projects, hopefully fostering long-term collaboration rather than factional in-fighting. The collaborative environment will speed the development of a healthy biotech research ecosystem in Nevada bringing hundreds of millions of dollars into the state (based on examples in other cities like New Orleans).

▪ Researchers in other parts of the country will take notice that Nevada ahs done something important in biotechnology research. Researchers in other parts of the country will wonder if they can do research in Nevada that they would be prevented from doing at their own institutions due to internal politics. Some talented investigators may choose to move their labs to Nevada in search of academic freedom.

• The state should create an entity that actively helps Nevada public and private research obtain grants supporting biotechnology.

• Our Health and Human Services Director should be replaced.